Ireton, Reneé C <br/><br/>
EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.  [electronic resource] 

 -  Current cancer drug targets  May 2005 
 - 149-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1568-0096 
<br/><br/><label>Standard No.: </label>10.2174/1568009053765780  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Humans<br/>Neoplasms--drug therapy<br/>Neovascularization, Pathologic--drug therapy<br/>Receptor, EphA2--biosynthesis